Evkeeza is now approved for the treatment of homozygous familial hypercholesterolemia (HoFH) in patients as young as 1 year ...
AstraZeneca will launch a new online platform to make Airsupra, as well as Farxiga and Flumist, available for home delivery ...
A new targeted therapy has shown promise for a difficult-to-treat subset of lung cancer. In a multinational phase 2 trial, the oral drug sunvozertinib produced durable tumor responses in patients with ...
Recent analysis reveals Medicaid's impact on mortality, highlighting the need for diverse research methods to inform policy ...
Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback